智通港股股东权益披露|9月5日

Group 1 - The latest shareholder equity disclosure for Stone Four Pharmaceutical Group (02005) and Huaxin Cement (06655) was conducted on September 5, 2025 [1] - China Pharmaceutical Company Limited increased its holdings in Stone Four Pharmaceutical Group from 878 million shares to 879 million shares, representing a holding percentage change from 29.74% to 29.77% [2] - Qu Jiguang increased his holdings in Stone Four Pharmaceutical Group from 1.169 billion shares to 1.170 billion shares, with a holding percentage change from 39.61% to 39.64% [2] Group 2 - Liu Weisheng acquired 20,000 shares in Huaxin Cement, changing his holding from 0 shares to 20,000 shares, resulting in a holding percentage of 0% [2]